- Collagenase Type I is a highly active extracellular‑matrix‑degrading enzyme widely used in biological research for dissociating dense connective tissues and isolating primary cells. Derived from Clostridium histolyticum, Collagenase Type I specifically targets collagen types I, II, III, and IV, making it particularly effective for tissues rich in fibrillar collagen such as adipose tissue, skin, muscle, and fibrous organs. By cleaving peptide bonds within collagen’s triple‑helical structure, Collagenase Type I reduces matrix rigidity and facilitates the release of embedded cells. Its strong enzymatic activity makes it indispensable in tissue dissociation, primary‑cell isolation, organoid preparation, and regenerative‑medicine workflows.
- Collagenase Type I is commonly used to isolate adipose‑derived stem cells, fibroblasts, hepatocytes, pancreatic cells, and epithelial cells from complex tissues. In adipose‑tissue workflows, it efficiently breaks down connective‑tissue networks, improving cell yield and viability. In pancreatic research, Collagenase Type I is used to dissociate exocrine tissue and support isolation of intact pancreatic islets. In neuroscience, it assists in dissociating brain tissue when combined with enzymes such as hyaluronidase or Dispase II. Its ability to degrade dense extracellular matrix also makes it valuable in organoid culture, where controlled tissue breakdown is required to generate uniform single‑cell suspensions for downstream expansion.
- Several manufacturers supply high‑quality Collagenase Type I formulations tailored for specific tissue types and research needs. Sigma‑Aldrich (Merck) offers Collagenase Type I with defined activity units suitable for adipose‑tissue digestion, fibroblast isolation, and general tissue dissociation. Worthington Biochemical Corporation provides highly purified Collagenase Type I with detailed activity specifications, making it suitable for clinical‑grade cell isolation and organoid preparation. STEMCELL Technologies includes Collagenase Type I in specialised dissociation kits designed for epithelial, neural, and organoid systems. These formulations vary in purity, protease content, and activity profiles, allowing researchers to select the optimal reagent for their specific workflow.
- Effective use of Collagenase Type I requires careful control of temperature, incubation time, and reagent concentration. Pre‑warming the enzyme solution enhances activity, while combining Collagenase Type I with complementary enzymes such as hyaluronidase or Dispase II improves dissociation of complex tissues. Digestion should be monitored under an inverted microscope to avoid over‑digestion, which can damage cells or reduce viability. Enzymatic activity must be neutralised promptly using serum‑containing medium or appropriate inhibitors. Gentle mechanical agitation, correct buffer composition, and sterile technique further support reproducible and high‑viability dissociation outcomes. When used correctly, Collagenase Type I provides strong, efficient, and controlled extracellular‑matrix degradation suitable for a wide range of biological applications.
- Overall, Collagenase Type I remains a cornerstone reagent in tissue‑processing workflows. Its ability to degrade collagen and loosen dense extracellular matrix supports high‑quality cell isolation across neuroscience, regenerative medicine, stem‑cell science, immunology, and organoid research. Whether used alone or in combination with other enzymes, Collagenase Type I provides reliable, efficient, and reproducible dissociation that preserves cell viability and supports downstream experimental success.
